TY - JOUR
T1 - Medication-related problems in ambulatory hemodialysis patients
T2 - A pooled analysis
AU - Manley, Harold J.
AU - Cannella, Carrie A.
AU - Bailie, George R.
AU - St. Peter, Wendy L.
PY - 2005/10
Y1 - 2005/10
N2 - •Background: Medication-related problems are common in hemodialysis (HD) patients. These patients often require 12 medications to treat 5 to 6 comorbid conditions. Medication-related problem research reports cannot be generalized to the entire HD population because data are obtained from single centers and limited numbers of patients. We conducted a pooled analysis to gain additional insight into the frequency, type, and severity of medication-related problems and extrapolated the data to the entire US HD population. Methods: Articles were identified through a MEDLINE search (1962 to March 2004). Seven studies were included in the analysis. Medication-related problems were categorized into the following 9 categories: indication without drug therapy, drug without indication, improper drug selection, subtherapeutic dosage, overdosage, adverse drug reaction, drug interaction, failure to receive drug, and inappropriate laboratory monitoring. A medication-related problem appearance rate was determined. Results: We identified 1,593 medication-related problems in 395 patients (51.2% men; age, 52.4 ± 8.2 years; 42.7% with diabetes). The most common medication-related problems found were inappropriate laboratory monitoring (23.5%) and indication without drug therapy (16.9%). Dosing errors accounted for 20.4% of medication-related problems (subtherapeutic dosage, 11.2%; overdosage, 9.2%). The medication-related problem appearance rate was 5.75e-0.37x, where x equals number of months of follow-up (P = 0.02). Conclusion: HD patients experience ongoing medication-related problems. Reduction in medication-related problems in dialysis patients may improve quality of life and result in decreased morbidity and mortality. Pharmacists are uniquely trained to detect and manage medication-related problems. Pharmacists should be an integral member of the dialysis health care team.
AB - •Background: Medication-related problems are common in hemodialysis (HD) patients. These patients often require 12 medications to treat 5 to 6 comorbid conditions. Medication-related problem research reports cannot be generalized to the entire HD population because data are obtained from single centers and limited numbers of patients. We conducted a pooled analysis to gain additional insight into the frequency, type, and severity of medication-related problems and extrapolated the data to the entire US HD population. Methods: Articles were identified through a MEDLINE search (1962 to March 2004). Seven studies were included in the analysis. Medication-related problems were categorized into the following 9 categories: indication without drug therapy, drug without indication, improper drug selection, subtherapeutic dosage, overdosage, adverse drug reaction, drug interaction, failure to receive drug, and inappropriate laboratory monitoring. A medication-related problem appearance rate was determined. Results: We identified 1,593 medication-related problems in 395 patients (51.2% men; age, 52.4 ± 8.2 years; 42.7% with diabetes). The most common medication-related problems found were inappropriate laboratory monitoring (23.5%) and indication without drug therapy (16.9%). Dosing errors accounted for 20.4% of medication-related problems (subtherapeutic dosage, 11.2%; overdosage, 9.2%). The medication-related problem appearance rate was 5.75e-0.37x, where x equals number of months of follow-up (P = 0.02). Conclusion: HD patients experience ongoing medication-related problems. Reduction in medication-related problems in dialysis patients may improve quality of life and result in decreased morbidity and mortality. Pharmacists are uniquely trained to detect and manage medication-related problems. Pharmacists should be an integral member of the dialysis health care team.
KW - Hemodialysis (HD)
KW - Medication-related problems
KW - Pharmacy
UR - https://www.scopus.com/pages/publications/25644432168
UR - https://www.scopus.com/pages/publications/25644432168#tab=citedBy
U2 - 10.1053/j.ajkd.2005.07.001
DO - 10.1053/j.ajkd.2005.07.001
M3 - Article
C2 - 16183422
AN - SCOPUS:25644432168
SN - 0272-6386
VL - 46
SP - 669
EP - 680
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 4
ER -